Search Results - "Moser, Ann B"

Refine Results
  1. 1

    Functions of plasmalogen lipids in health and disease by Braverman, Nancy E., Moser, Ann B.

    Published in Biochimica et biophysica acta (01-09-2012)
    “…Plasmalogens are a unique class of membrane glycerophospholipids containing a fatty alcohol with a vinyl-ether bond at the sn-1 position, and enriched in…”
    Get full text
    Journal Article
  2. 2

    X‐linked adrenoleukodystrophy: Pathology, pathophysiology, diagnostic testing, newborn screening and therapies by Turk, Bela R., Theda, Christiane, Fatemi, Ali, Moser, Ann B.

    “…Adrenoleukodystrophy (ALD) is a rare X‐linked disease caused by a mutation of the peroxisomal ABCD1 gene. This review summarizes our current understanding of…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Homeostasis of phospholipids — The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens by Dorninger, Fabian, Brodde, Alexander, Braverman, Nancy E., Moser, Ann B., Just, Wilhelm W., Forss-Petter, Sonja, Brügger, Britta, Berger, Johannes

    Published in Biochimica et biophysica acta (01-02-2015)
    “…Ethanolamine plasmalogens constitute a group of ether glycerophospholipids that, due to their unique biophysical and biochemical properties, are essential…”
    Get full text
    Journal Article
  7. 7

    A liver-specific defect of Acyl-CoA degradation produces hyperammonemia, hypoglycemia and a distinct hepatic Acyl-CoA pattern by Gauthier, Nicolas, Wu, Jiang Wei, Wang, Shu Pei, Allard, Pierre, Mamer, Orval A, Sweetman, Lawrence, Moser, Ann B, Kratz, Lisa, Alvarez, Fernando, Robitaille, Yves, Lépine, François, Mitchell, Grant A

    Published in PloS one (05-07-2013)
    “…Most conditions detected by expanded newborn screening result from deficiency of one of the enzymes that degrade acyl-coenzyme A (CoA) esters in mitochondria…”
    Get full text
    Journal Article
  8. 8

    Newborn Screening for X-Linked Adrenoleukodystrophy: Past, Present, and Future by Moser, Ann B, Seeger, Elisa, Raymond, Gerald V

    “…Newborn screening for X-linked adrenoleukodystrophy began in New York in 2013. Prior to this start, there was already significant information on the diagnosis…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Role of ACSBG1 in Brain Lipid Metabolism and X-Linked Adrenoleukodystrophy Pathogenesis: Insights from a Knockout Mouse Model by Ye, Xiaoli, Li, Yuanyuan, González-Lamuño, Domingo, Pei, Zhengtong, Moser, Ann B, Smith, Kirby D, Watkins, Paul A

    Published in Cells (Basel, Switzerland) (12-10-2024)
    “…"Bubblegum" acyl-CoA synthetase (ACSBG1) is a pivotal player in lipid metabolism during mouse brain development, facilitating the activation of long-chain…”
    Get full text
    Journal Article
  11. 11

    Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy? by Eichler, Florian S., Ren, Jia-Qian, Cossoy, Michael, Rietsch, Anna M., Nagpal, Sameer, Moser, Ann B., Frosch, Matthew P., Ransohoff, Richard M.

    Published in Annals of neurology (01-06-2008)
    “…Objective Mutations in the X‐linked adrenoleukodystrophy (X‐ALD) protein cause accumulation of unbranched saturated very‐long‐chain fatty acids, particularly…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Newborn Screening for X-Linked Adrenoleukodystrophy by Moser, Ann B, Jones, Richard O, Hubbard, Walter C, Tortorelli, Silvia, Orsini, Joseph J, Caggana, Michele, Vogel, Beth H, Raymond, Gerald V

    “…Early diagnosis of males with X-linked adrenoleukodystrophy (X-ALD) is essential for preventing loss of life due to adrenal insufficiency and for timely…”
    Get full text
    Journal Article
  15. 15
  16. 16

    MicroRNA and metabolomics signatures for adrenomyeloneuropathy disease severity by Turk, Bela Rui, Poisson, Laila Marie, Nemeth, Christina Linnea, Goodman, Jordan, Moser, Ann B., Jones, Richard Owen, Fatemi, Ali, Singh, Jaspreet

    Published in JIMD reports (01-11-2022)
    “…Adrenomyeloneuropathy (AMN), the slow progressive phenotype of adrenoleukodystrophy (ALD), has no clinical plasma biomarker for disease progression. This…”
    Get full text
    Journal Article
  17. 17

    Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease by Ribbens, Jameson J., Moser, Ann B., Hubbard, Walter C., Bongarzone, Ernesto R., Maegawa, Gustavo H.B.

    Published in Molecular genetics and metabolism (01-02-2014)
    “…Disease-cell models that recapitulate specific molecular phenotypes are essential for the investigation of molecular pathogenesis of neurodegenerative diseases…”
    Get full text
    Journal Article
  18. 18

    Vitamin D status and latitude predict brain lesions in adrenoleukodystrophy by Keith P. vanHaren, Jacob Wilkes, Ann B. Moser, Gerald V. Raymond, Troy Richardson, Patrick Aubourg, Timothy W. Collins, Ellen M. Mowry, Joshua L. Bonkowsky

    Published in Annals of the Child Neurology Society (01-06-2023)
    “…Abstract Objectives Approximately 40% of boys with X‐linked adrenoleukodystrophy (ALD) develop inflammatory demyelinating brain lesions (cerebral ALD, cALD)…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Clinical, biochemical, and mutational spectrum of peroxisomal acyl-coenzyme A oxidase deficiency by Ferdinandusse, Sacha, Denis, Simone, Hogenhout, Eveline M., Koster, Janet, van Roermund, Carlo W.T., IJlst, Lodewijk, Moser, Ann B., Wanders, Ronald J.A., Waterham, Hans R.

    Published in Human mutation (01-09-2007)
    “…Peroxisomal acyl–coenzyme A (acyl‐CoA) oxidase deficiency is an autosomal recessive inborn error of peroxisomal fatty acid oxidation due to a deficiency of…”
    Get full text
    Journal Article